Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00034307
Status:
UNKNOWN
Last Update Posted:
2005-06-24
First Post:
2002-04-24
Brief Title:
Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension
Sponsor:
ICOS-Texas Biotechnology
Organization:
ICOS-Texas Biotechnology
Organization Data
Organization:
ICOS-Texas Biotechnology
Class:
INDUSTRY
Study ID:
FPH01FPH01-X
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ICOS-Texas Biotechnology
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| ICOS Corporation | INDUSTRY |
| Texas Biotechnology Corporation | INDUSTRY |